Fig. 9
From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
Correlation between the expression of SLC39A1 and immune infiltration of patient with glioma. a Correlations between SLC39A1 expression and immune, stromal, and tumor purity scores (from ESTIMATE). b The varied proportions of 22 subtypes of immune cells in high and low SLC39A1 expression groups in glioma samples. c Heatmap of 22 immune infiltration cells in glioma samples